|
- Diving Deeper into Cholesterol: Sterol Testing with Dr. Dayspring
According to the Framingham Offspring Study, people who are cholesterol hyperabsorbers are at increased risk of cardiovascular disease The markers of increased absorption are Campesterol, Sitosterol, and Cholestanol
- The effect of dietary cholesterol on blood cholesterol individual . . .
We cover cholesterol absorption in the intestine, the effect on serum cholesterol, tests of absorption status, and actionable advice to lower risk
- What causes cardiovascular disease (Lipid Series - Part 1) | Dr Thomas . . .
Episode #251 forms Part One of this series In this conversation, Dr Dayspring provides the foundational, technical knowledge needed to understand blood lipids, taking a deep dive into how our body absorbs lipids (fats and sterols) and transports them throughout the body
- Lipids Lipidology: Wisdom for the Heart
In the second half of my conversation with Dr Dayspring, we explored pharmaceutical strategies for managing lipids—particularly focusing on lowering ApoB levels to reduce cardiovascular risk
- Ep 494: We Got Cholesterol All Wrong–The Most Shocking Truth About . . .
Today, we have the first episode in a new series of conversations with Dr Dayspring, in which he will share more of his perspective and answer more questions from listeners
- Our first guest: Dr. Thomas Dayspring. . . - Page 17 - ApoE4. Info
Using a huge dataset, Dr Dayspring separates folks by APOE genotypes and examines cholesterol absorption synthesis biomarkers Not surprisingly, (in general) E4 carriers were found to be hyperabsorbers, especially of beta-sitosterol
- Understanding Sterols Thomas Dayspring MD, FACP - LipidCenter
thing to do with the absorption of fatty acids Most humans absorb about 50% of the sterols in the gut, but some people are hyp absorbers (60-80%) and some are hypoabsorbers Ezetimibe (Zetia) blocks sterol absorption from micelles by interfering (bindi g to) with NPC1L1 in the intestinal epithelium Ezetimibe t
- #129 – Tom Dayspring, M. D. : The latest insights into cardiovascular . . .
World-renowned lipidologist Tom Dayspring returns to give an update on the current thinking in lipidology as a follow-up to his 2018 five-part podcast series In this episode, Tom discusses the growing consensus that atherogenic lipoproteins are essential drivers of atherosclerotic vascular disease
|
|
|